Financial insights of NXGLW

MyFinsight

For the year ending 2025-12-31, NXGLW made $11,421K in revenue. -$3,000K in net income. Net profit margin of -26.27%.

Income Statement	2025-12-31
Revenues, net	11,421
Cost of revenues	6,912
Gross profit	4,509
Research and development	2
Selling, general and administrative	7,859
Total operating expenses	7,861
Loss from operations	-3,352
Change in fair value of warrant liability, net of warrant modification expense	118
Interest expense, net	34
Gain in spin-off of nexgelrx	162
Other expense	73
Other income	286
Total other income (expense), net	459
Loss before income taxes	-2,893
Net loss	-2,893
Less loss attributable to non-controlling interest in joint venture	107
Net loss attributable to nexgel stockholders	-3,000

Basic EPS	-0.38
Diluted EPS	-0.38
Basic Average Shares	7,854,288
Diluted Average Shares	7,854,288

Unit: Thousand (K) dollars (except for numbers of shares and EPS).